• Publications
  • Influence
Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).
OBJECTIVE This study aimed to identify trends in the use of antipsychotic polypharmacy (APP) and their demographic and clinical correlates in the treatment of schizophrenia in Asia between 2001 andExpand
  • 50
  • 3
  • PDF
Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009.
OBJECTIVE The aim of this study was to survey the use of anticholinergic medication (ACM) in Asia between 2001 and 2009 and examine its demographic and clinical correlates. METHOD A total of 6 761Expand
  • 13
  • 1
  • PDF
Antidepressant-induced tardive syndrome: a retrospective epidemiological study.
INTRODUCTION The impact of using antidepressant on the occurrence of tardive syndrome is rarely studied. Here we aimed to investigate the prevalence of various types of antidepressant induced tardiveExpand
  • 10
  • 1
Risk of Extrapyramidal Syndrome in Schizophrenic Patients Treated with Antipsychotics: A Population‐based Study
To compare the prevalence of extrapyramidal syndrome (EPS) between the first‐generation antipsychotics (FGAs) and second‐generation antipsychotics (SGAs), the co‐prescribing rate of anti‐ParkinsonExpand
  • 41
Tardive dyskinesia in the treatment of schizophrenia: the findings of the Research on Asian Psychotropic Prescription Pattern (REAP) survey (2001 - 2009).
OBJECTIVE The aim of the study was to survey the frequency of tardive dyskinesia (TD) in patients with schizophrenia and its demographic and clinical correlates in selected Asian countries. METHODExpand
  • 10
  • PDF
Adjunctive mood stabilizer and benzodiazepine use in older Asian patients with schizophrenia, 2001-2009.
OBJECTIVE This study surveyed the use of adjunctive mood stabilizers (MS) and benzodiazepines (BZD) in older Asian schizophrenia patients and examined their demographic and clinical correlates. Expand
  • 7
  • PDF
LBP‐016: Lost to follow‐up among Ledipasvir/sofosbuvir treated patients in Canada: The BC Hepatitis Testers Cohort
Results: We found a prevalence of 22.5% (HBV) and 0.9 (HCV). The majority of blood donations were familial for HBV (87.8%) and HCV (100%). The average age of donors with HBV was 20–14 years. TheExpand
LBP‐017: Dried blood spot samples as alternative specimen for hepatitis C diagnosis
Results: We found a prevalence of 22.5% (HBV) and 0.9 (HCV). The majority of blood donations were familial for HBV (87.8%) and HCV (100%). The average age of donors with HBV was 20–14 years. TheExpand